<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00270855</url>
  </required_header>
  <id_info>
    <org_study_id>B3918-R</org_study_id>
    <secondary_id>UL1RR031990</secondary_id>
    <nct_id>NCT00270855</nct_id>
  </id_info>
  <brief_title>Exercise to Reduce Obesity in Spinal Cord Injury</brief_title>
  <official_title>Exercise to Reduce Obesity in Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this proposal was to evaluate and compare the health benefits of using upper
      extremity exercise versus functional electrical stimulation for lower extremity exercise. It
      was our hypothesis that both Functional Electrical Stimulation Leg Cycle Ergometry (FES LCE)
      exercise and voluntary Arm Crank Ergometry (ACE) upper extremity exercise would increase
      whole body energy expenditure, thereby increasing muscle mass, insulin sensitivity, glucose
      effectiveness and improving lipid profiles in adults with paraplegia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: Spinal cord injuries (SCI) predispose individuals to impaired fitness, obesity,
      glucose intolerance and insulin resistance, placing them at greater risk for diabetes,
      coronary artery disease, and upper extremity overuse syndrome as body weight increases. The
      specific objectives for the current proposal were to compare the impact of FES (functional
      electrical stimulation) lower extremity exercise versus upper extremity arm crank ergometry
      on energy metabolism, body composition and fat deposition, insulin sensitivity, glucose
      effectiveness, lower extremity bone mineral density and lipid profiles, in adults with
      complete paraplegia. Research Plan: A randomized, baseline-controlled, prospective, 16-week
      interventional trial was employed to assess the impact of FES LCE versus volitional arm crank
      ergometry exercise on energy metabolism, body composition and fat deposition, insulin
      sensitivity, glucose effectiveness, lower extremity bone mineral density and lipid profiles
      in adults with complete paraplegia. Methods: Twenty-four 18-65 y.o. individuals with motor
      complete T4-L2 SCI were assigned to either FES lower extremity exercise or upper extremity
      arm crank ergometry to compare impact on energy expenditure, obesity, and insulin
      sensitivity. Both groups were provided similar nutritional assessments and intervention.
      Exercise training consisted of five, 40-minute sessions at 70% maximal heart rate (HRmax)
      each week for a total of 16 weeks. Resting metabolic rate, exercise energy expenditure, body
      composition by DXA, insulin sensitivity, glucose effectiveness, lipid profiles, and lower
      extremity bone mineral density (BMD) were determined before and after 16-week exercise
      interventions.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in % Body Fat</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Change in % Body Fat after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Fat Mass</measure>
    <time_frame>Baseline, 16 Weeks</time_frame>
    <description>Change in Fat Mass (Kg) after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Fat-Free Mass</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Fat-Free Mass (kg). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Glucose Effectiveness (Sg)</measure>
    <time_frame>Baseline, 16-weeks</time_frame>
    <description>Change in Glucose Effectiveness (min^-1). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Insulin Sensitivity (Si)</measure>
    <time_frame>Baseline, 16-weeks</time_frame>
    <description>Change in insulin sensitivity (min^-1). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>%Body Fat Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of %body fat between the ACE and FESLCE groups following the 16 week intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fat Mass Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of fat mass between the ACE and FESLCE groups following the 16 week intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fat Free Mass Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of fat free mass between the ACE and FESLCE groups following the 16 week intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin Sensitivity (Si) Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of Si between the ACE and FESLCE groups following the 16 week intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose Effectiveness (Sg) Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of Sg between the ACE and FESLCE groups following the 16 week intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Lower Limb Bone Mineral Density</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Change in lower limb bone mineral density after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Lower Limb Bone Mineral Content</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Change in lower limb bone mineral content after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Triglycerides</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Change in triglycerides after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in High Density Lipoprotein Cholesterol (HDL)</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Change in HDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Low Density Lipoprotein Cholesterol (LDL)</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Change in LDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Total Cholesterol (TC)</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Change in TC after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL)</measure>
    <time_frame>Baseline, 16 weeks</time_frame>
    <description>Change in TC:HDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lower Limb Bone Mineral Density Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of Lower limb bone mineral density between the ACE and FESLCE groups following the 16 week intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lower Limb Bone Mineral Content Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of Lower limb bone mineral content between the ACE and FESLCE groups following the 16 week intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of Triglycerides between the ACE and FESLCE groups following the 16 week intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Density Lipoprotein Cholesterol (HDL) Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of HDL between the ACE and FESLCE groups following the 16 week intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low Density Lipoprotein Cholesterol (LDL) Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of LDL between the ACE and FESLCE groups following the 16 week intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol (TC) Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of TC between the ACE and FESLCE groups following the 16 week intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL) Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL) between the ACE and FESLCE groups following the 16 week intervention</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Resting Metabolic Rate</measure>
    <time_frame>baseline, 16 weeks</time_frame>
    <description>Change in resting metabolic rate after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
  </other_outcome>
  <other_outcome>
    <measure>Resting Metabolic Rate Between Groups</measure>
    <time_frame>16 weeks</time_frame>
    <description>Comparison of resting metabolic rate between the ACE and FESLCE groups following the 16 week intervention</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Obesity</condition>
  <condition>Paraplegia</condition>
  <condition>Quadriplegia</condition>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>Arm Crank Ergometer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Upper body Cycle ergometer Exercise: 10-minute warm up, 40 minutes @ 70%HRMax (50RPM), 10 minute cool down 5x/week x 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FESLCE</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Functional Electrical Stimulation Leg Cycle Ergometer Exercise: 10-minute warm up, 40 minutes @ 70%HRMax (50RPM), 10 minute cool down 5x/week x 16 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arm Crank Ergometry</intervention_name>
    <description>Use of an upper body cycle to perform exercise. 10-minute warm up, 40 minutes @ 70%HRMax (50RPM), 10 minute cool down 5x/week x 16 weeks</description>
    <arm_group_label>Arm Crank Ergometer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FES Cycle Ergometer</intervention_name>
    <description>Use of an FES cycle ergometer to perform exercise. 10-minute warm up, 40 minutes @ 70%HRMax (50RPM), 10 minute cool down 5x/week x 16 weeks</description>
    <arm_group_label>FESLCE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Criteria for participation included men and women within the age range of 18-65 years old
        with BMI&gt;25 kg/m2 who have had T4-L2 Motor-Complete (ASIA A&amp;B) SCI for duration of greater
        than 12 months to ensure a homogenous sample.

        Exclusion Criteria:

          -  persons who were unresponsive to surface neurostimulation

          -  had participated in an FES or ACE exercise (&gt; 60 minutes/week) program within the past
             3 months

          -  and those with known orthopedic limitations

          -  CAD

          -  diabetes mellitus (fasting glucose&gt;126 or HgbA1c&gt;7.0) or known family history

          -  hypothyroidism

          -  and/or renal disease were excluded from the study.

          -  Additionally, individuals with uncontrolled autonomic dysreflexia, recent (within 3
             months) deep vein thrombosis, or pressure ulcers &gt; Grade II were excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David R Gater, MD PhD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hunter Holmes McGuire VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hunter Holmes McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2005</study_first_submitted>
  <study_first_submitted_qc>December 23, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2005</study_first_posted>
  <results_first_submitted>October 7, 2016</results_first_submitted>
  <results_first_submitted_qc>October 13, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">November 17, 2017</results_first_posted>
  <last_update_submitted>October 13, 2017</last_update_submitted>
  <last_update_submitted_qc>October 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Body Composition</keyword>
  <keyword>Exercise</keyword>
  <keyword>Glucose Tolerance</keyword>
  <keyword>Insulin Sensitivity</keyword>
  <keyword>Functional Electric Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Paraplegia</mesh_term>
    <mesh_term>Quadriplegia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm Crank Ergometer</title>
          <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
        </group>
        <group group_id="P2">
          <title>FESLCE</title>
          <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm Cycling Ergometer</title>
          <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
        </group>
        <group group_id="B2">
          <title>FESLCE</title>
          <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="13"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42" spread="10"/>
                    <measurement group_id="B2" value="39" spread="14"/>
                    <measurement group_id="B3" value="40.5" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>% Body Fat</title>
          <units>Percent Body Fat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.9" spread="6.9"/>
                    <measurement group_id="B2" value="41.6" spread="7.1"/>
                    <measurement group_id="B3" value="40.75" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fat Mass (Kg)</title>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.6" spread="6.4"/>
                    <measurement group_id="B2" value="33.4" spread="11.0"/>
                    <measurement group_id="B3" value="31.5" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fat-Free Mass (kg)</title>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.6" spread="9.1"/>
                    <measurement group_id="B2" value="49.5" spread="11.2"/>
                    <measurement group_id="B3" value="49.55" spread="10.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glucose Effectiveness (Sg)</title>
          <units>min^-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.023" spread="0.01"/>
                    <measurement group_id="B2" value="0.017" spread="0.01"/>
                    <measurement group_id="B3" value="0.02" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insulin Sensitivity (Si)</title>
          <units>Î¼u/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.0" spread="2.0"/>
                    <measurement group_id="B2" value="2.7" spread="2.0"/>
                    <measurement group_id="B3" value="2.85" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Exercise Energy Expenditure (Kcal/session)</title>
          <units>Kcal/session</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="128.3" spread="35.4"/>
                    <measurement group_id="B2" value="80.7" spread="32.6"/>
                    <measurement group_id="B3" value="101" spread="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Resting Metabolic Rate</title>
          <units>Kcal/d</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1442" spread="348"/>
                    <measurement group_id="B2" value="1710" spread="974"/>
                    <measurement group_id="B3" value="1565" spread="689"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total Cholesterol</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="176" spread="29"/>
                    <measurement group_id="B2" value="167" spread="49"/>
                    <measurement group_id="B3" value="172" spread="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HDL-Cholesterol</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.7" spread="6.4"/>
                    <measurement group_id="B2" value="37.8" spread="8.3"/>
                    <measurement group_id="B3" value="36.7" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Bone Mineral Density</title>
          <units>g/cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.138" spread="0.104"/>
                    <measurement group_id="B2" value="1.293" spread="0.135"/>
                    <measurement group_id="B3" value="1.209" spread="0.140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in % Body Fat</title>
        <description>Change in % Body Fat after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in % Body Fat</title>
          <description>Change in % Body Fat after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>Percent Body Fat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.83" spread="2.72"/>
                    <measurement group_id="O2" value="-1.68" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group (i.e, baseline vs. post-intervention in ARE)</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group (i.e, baseline vs. post-intervention in FESLCE)</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Fat Mass</title>
        <description>Change in Fat Mass (Kg) after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>Baseline, 16 Weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fat Mass</title>
          <description>Change in Fat Mass (Kg) after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.84" spread="1.99"/>
                    <measurement group_id="O2" value="-1.02" spread="2.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Fat-Free Mass</title>
        <description>Fat-Free Mass (kg). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fat-Free Mass</title>
          <description>Fat-Free Mass (kg). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="3.49"/>
                    <measurement group_id="O2" value="1.86" spread="2.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>0.519</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Glucose Effectiveness (Sg)</title>
        <description>Change in Glucose Effectiveness (min^-1). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>Baseline, 16-weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Crank Ergometer</title>
            <description>Upper body Cycle ergometer Exercise: 10-minute warm up, 40 minutes @ 70%HRMax (50RPM), 10 minute cool down 5x/week x 16 weeks
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Leg Cycle Ergometer Exercise: 10-minute warm up, 40 minutes @ 70%HRMax (50RPM), 10 minute cool down 5x/week x 16 weeks
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Glucose Effectiveness (Sg)</title>
          <description>Change in Glucose Effectiveness (min^-1). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>min^-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.02"/>
                    <measurement group_id="O2" value="0.01" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>0.615</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Insulin Sensitivity (Si)</title>
        <description>Change in insulin sensitivity (min^-1). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>Baseline, 16-weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Crank Ergometer</title>
            <description>Upper body Cycle ergometer Exercise: 10-minute warm up, 40 minutes @ 70%HRMax (50RPM), 10 minute cool down 5x/week x 16 weeks
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Leg Cycle Ergometer Exercise: 10-minute warm up, 40 minutes @ 70%HRMax (50RPM), 10 minute cool down 5x/week x 16 weeks
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Insulin Sensitivity (Si)</title>
          <description>Change in insulin sensitivity (min^-1). Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>min^-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="25.3"/>
                    <measurement group_id="O2" value="5.28" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>%Body Fat Between Groups</title>
        <description>Comparison of %body fat between the ACE and FESLCE groups following the 16 week intervention.</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>%Body Fat Between Groups</title>
          <description>Comparison of %body fat between the ACE and FESLCE groups following the 16 week intervention.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>Percent Body Fat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.1" spread="5.6"/>
                    <measurement group_id="O2" value="39.9" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fat Mass Between Groups</title>
        <description>Comparison of fat mass between the ACE and FESLCE groups following the 16 week intervention.</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Fat Mass Between Groups</title>
          <description>Comparison of fat mass between the ACE and FESLCE groups following the 16 week intervention.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.6" spread="6.4"/>
                    <measurement group_id="O2" value="33.4" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fat Free Mass Between Groups</title>
        <description>Comparison of fat free mass between the ACE and FESLCE groups following the 16 week intervention.</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Fat Free Mass Between Groups</title>
          <description>Comparison of fat free mass between the ACE and FESLCE groups following the 16 week intervention.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.5" spread="10.4"/>
                    <measurement group_id="O2" value="51.3" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Insulin Sensitivity (Si) Between Groups</title>
        <description>Comparison of Si between the ACE and FESLCE groups following the 16 week intervention.</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Sensitivity (Si) Between Groups</title>
          <description>Comparison of Si between the ACE and FESLCE groups following the 16 week intervention.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>min^-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7" spread="0.02"/>
                    <measurement group_id="O2" value="8.4" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Glucose Effectiveness (Sg) Between Groups</title>
        <description>Comparison of Sg between the ACE and FESLCE groups following the 16 week intervention.</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Glucose Effectiveness (Sg) Between Groups</title>
          <description>Comparison of Sg between the ACE and FESLCE groups following the 16 week intervention.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>min^-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".03" spread="0.009"/>
                    <measurement group_id="O2" value="0.02" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Lower Limb Bone Mineral Density</title>
        <description>Change in lower limb bone mineral density after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Lower Limb Bone Mineral Density</title>
          <description>Change in lower limb bone mineral density after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>g*(cm^2)^-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.03"/>
                    <measurement group_id="O2" value="-0.01" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Lower Limb Bone Mineral Content</title>
        <description>Change in lower limb bone mineral content after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Lower Limb Bone Mineral Content</title>
          <description>Change in lower limb bone mineral content after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.14"/>
                    <measurement group_id="O2" value="-0.06" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Triglycerides</title>
        <description>Change in triglycerides after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Triglycerides</title>
          <description>Change in triglycerides after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.14" spread="22.6"/>
                    <measurement group_id="O2" value="-12.33" spread="8.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Wilcoxon signed-rank test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in High Density Lipoprotein Cholesterol (HDL)</title>
        <description>Change in HDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in High Density Lipoprotein Cholesterol (HDL)</title>
          <description>Change in HDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.29" spread="3.55"/>
                    <measurement group_id="O2" value="0.07" spread="2.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Low Density Lipoprotein Cholesterol (LDL)</title>
        <description>Change in LDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Low Density Lipoprotein Cholesterol (LDL)</title>
          <description>Change in LDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="20.7"/>
                    <measurement group_id="O2" value="1.43" spread="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Total Cholesterol (TC)</title>
        <description>Change in TC after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Total Cholesterol (TC)</title>
          <description>Change in TC after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.14" spread="22.6"/>
                    <measurement group_id="O2" value="-12.33" spread="8.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL)</title>
        <description>Change in TC:HDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>Baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL)</title>
          <description>Change in TC:HDL after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.59"/>
                    <measurement group_id="O2" value="-0.22" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lower Limb Bone Mineral Density Between Groups</title>
        <description>Comparison of Lower limb bone mineral density between the ACE and FESLCE groups following the 16 week intervention</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Lower Limb Bone Mineral Density Between Groups</title>
          <description>Comparison of Lower limb bone mineral density between the ACE and FESLCE groups following the 16 week intervention</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>g*(cm^2)^-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="0.12"/>
                    <measurement group_id="O2" value="1.28" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lower Limb Bone Mineral Content Between Groups</title>
        <description>Comparison of Lower limb bone mineral content between the ACE and FESLCE groups following the 16 week intervention</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Lower Limb Bone Mineral Content Between Groups</title>
          <description>Comparison of Lower limb bone mineral content between the ACE and FESLCE groups following the 16 week intervention</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.37" spread="0.64"/>
                    <measurement group_id="O2" value="2.88" spread="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Triglycerides Between Groups</title>
        <description>Comparison of Triglycerides between the ACE and FESLCE groups following the 16 week intervention</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Triglycerides Between Groups</title>
          <description>Comparison of Triglycerides between the ACE and FESLCE groups following the 16 week intervention</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.33" spread="46.7"/>
                    <measurement group_id="O2" value="103.6" spread="65.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Density Lipoprotein Cholesterol (HDL) Between Groups</title>
        <description>Comparison of HDL between the ACE and FESLCE groups following the 16 week intervention</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>High Density Lipoprotein Cholesterol (HDL) Between Groups</title>
          <description>Comparison of HDL between the ACE and FESLCE groups following the 16 week intervention</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.43" spread="5.1"/>
                    <measurement group_id="O2" value="37.8" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney-u test was performed</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Low Density Lipoprotein Cholesterol (LDL) Between Groups</title>
        <description>Comparison of LDL between the ACE and FESLCE groups following the 16 week intervention</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Low Density Lipoprotein Cholesterol (LDL) Between Groups</title>
          <description>Comparison of LDL between the ACE and FESLCE groups following the 16 week intervention</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118.3" spread="32.2"/>
                    <measurement group_id="O2" value="107.3" spread="35.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney U test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Cholesterol (TC) Between Groups</title>
        <description>Comparison of TC between the ACE and FESLCE groups following the 16 week intervention</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Total Cholesterol (TC) Between Groups</title>
          <description>Comparison of TC between the ACE and FESLCE groups following the 16 week intervention</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172.0" spread="28.6"/>
                    <measurement group_id="O2" value="163.7" spread="38.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>we evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>We used a Mann-Whitney U test.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL) Between Groups</title>
        <description>Comparison of Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL) between the ACE and FESLCE groups following the 16 week intervention</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL) Between Groups</title>
          <description>Comparison of Ratio of Total Cholesterol to High Density Lipoprotein Cholesterol (TC:HDL) between the ACE and FESLCE groups following the 16 week intervention</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="1.4"/>
                    <measurement group_id="O2" value="4.5" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A mann-whitney u test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change in Resting Metabolic Rate</title>
        <description>Change in resting metabolic rate after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
        <time_frame>baseline, 16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Resting Metabolic Rate</title>
          <description>Change in resting metabolic rate after 16 week intervention. Change score was calculated as final value (i.e., post intervention variable) minus baseline value.</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>kcal/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-131.7" spread="393"/>
                    <measurement group_id="O2" value="-322.0" spread="963"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the ACE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences between baseline and following the 16-week exercise intervention in the FESLCE group</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Wilcoxon signed-rank test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Resting Metabolic Rate Between Groups</title>
        <description>Comparison of resting metabolic rate between the ACE and FESLCE groups following the 16 week intervention</description>
        <time_frame>16 weeks</time_frame>
        <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm Cycling Ergometer</title>
            <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
          </group>
          <group group_id="O2">
            <title>FESLCE</title>
            <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Resting Metabolic Rate Between Groups</title>
          <description>Comparison of resting metabolic rate between the ACE and FESLCE groups following the 16 week intervention</description>
          <population>Two exercise groups consisted of an arm crank ergometry group and an FESLCE group.</population>
          <units>kcal/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1309.06" spread="167.9"/>
                    <measurement group_id="O2" value="1387.8" spread="392.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We evaluated differences in the above variable between the ACE and FESLCE following the the 16-week exercise intervention</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A Mann-Whitney U test was performed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm Cycling Ergometer</title>
          <description>Upper body Cycle ergometer
Arm Crank Ergometry: Use of an upper body cycle to perform exercise.</description>
        </group>
        <group group_id="E2">
          <title>FESLCE</title>
          <description>Functional Electrical Stimulation Cycle Ergometer for Lower body
FES Cycle Ergometer: Use of an FES cycle ergometer to perform exercise</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The number of subjects that withdrew lead to small numbers of subjects analyzed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. David Gater</name_or_title>
      <organization>Penn State Hershey Medical Center</organization>
      <phone>7175314263</phone>
      <email>dgater@hmc.psu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

